A Trial to Assess the Antipsychotic Efficacy of ITI-007

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Schizophrenia
Interventions
DRUG

ITI-007

DRUG

Placebo

Trial Locations (11)

Unknown

Clinical Site, Little Rock

Clinical Site, Springdale

Clinical Site, Escondido

Clinical Site, Garden Grove

Clinical Site, Long Beach

Clinical Site, San Diego

Clinical Site, Fort Lauderdale

Clinical Site, Rockville

Clinical Site, St Louis

Clinical Site, Marlton

Clinical Site, Austin

Sponsors
All Listed Sponsors
lead

Intra-Cellular Therapies, Inc.

INDUSTRY

NCT02282761 - A Trial to Assess the Antipsychotic Efficacy of ITI-007 | Biotech Hunter | Biotech Hunter